Turn Therapeutics Inc.
TTRX
$3.53
$0.030.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -1.90M | -784.50K | -784.50K | -666.40K | |
| Total Depreciation and Amortization | 13.70K | 12.50K | 12.50K | 12.10K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 39.40K | 187.30K | 187.30K | 248.60K | |
| Change in Net Operating Assets | 1.26M | 185.70K | 185.70K | 29.40K | |
| Cash from Operations | -588.60K | -399.00K | -399.00K | -376.30K | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -89.80K | -15.90K | -15.90K | -43.50K | |
| Cash from Investing | -89.80K | -15.90K | -15.90K | -43.50K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 594.60K | 1.57M | 1.57M | 323.50K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 594.60K | 1.57M | 1.57M | 323.50K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -83.80K | 1.16M | 1.16M | -96.20K | |